Correction: The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma
Crossref DOI link: https://doi.org/10.1186/s13046-024-03126-4
Published Online: 2024-07-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feng, Mei
Xu, Hao
Zhou, Wenyuan
Pan, Yisheng
Text and Data Mining valid from 2024-07-20
Version of Record valid from 2024-07-20
Article History
First Online: 20 July 2024